Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing

European Journal of Pharmacology

Volumn 536, Issue 3, 2006, Pages 301-308

  Guo, Jin Sheng ^a,b   Cho, Chi Hin ^b   Wang, Ji Yao ^a   Koo, Marcel Wing Leung ^b  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

COX 2 (cyclooxygenase 2); eNOS (endothelial nitric oxide synthase); iNOS (inducible nitric oxide synthase); L NAME (NG nitro l arginine methyl ester); N (3 (aminomethyl)benzyl)acetamidine (1400W); NF B (nuclear transcription factor B)

Indexed keywords

ACETIC ACID; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH ULCER; ULCER HEALING;

ACETIC ACID; AMIDINES; ANIMALS; BENZYLAMINES; BLOTTING, WESTERN; CYCLOOXYGENASE 2; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; NF-KAPPA B; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH; STOMACH ULCER; TIME FACTORS; WOUND HEALING;

EID: 33646470979     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.088     Document Type: Article

References (41)

1. Ahmad N., Chen L.C., Gordon M.A., Laskin J.D., and Laskin D.L. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J. Leukoc. Biol. 71 (2002) 1005-1011
2. Akiba Y., Nakamura M., Mori M., Suzuki H., Oda M., Kimura H., Miura S., Tsuchiya M., and Ishii H. Inhibition of inducible nitric oxide synthase delays gastric ulcer healing in the rat. J. Clin. Gastroenterol. 27 (1998) S64-S73
3. Babu B.R., and Griffith O.W. Design of isoform-selective inhibitors of nitric oxide synthase. Curr. Opin. Chem. Biol. 2 (1998) 491-500
4. Barry O.P., Kazanietz M.G., Pratico D., and FitzGerald G.A. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2 dependent prostaglandin formation via a protein kinase C/mitogen activated protein kinase-dependent pathway. J. Biol. Chem. 274 (1999) 7545-7556
5. Bolli R., Dawn B., and Xuan Y.T. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc. Med. 13 (2003) 72-79
6. Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., Day R., Ferraz M.B., Hawkey C.J., Hochberg M.C., Kvien T.K., and Schnitzer T.J. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N. Engl. J. Med. 343 (2000) 1520-1528
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilization the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
8. Brooks P., Emery P., Evans J.F., Fenner H., Hawkey C.J., Patrono C., Smolen J., Breedveld D., Day R., Dougados M., Ehrich E.W., Gijon-Banos J., Kvien T.K., Van Rijswijk M.H., Warner T., and Zeidler H. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-2. Rheumatology 38 (1999) 779-788
9. Cannon G.W., and Breedveld F.C. Efficacy of cyclooxygenase-2-specific inhibitors. Am. J. Med. (2001) 6S-12S
10. Chen F., Kuhn D.C., Sun S.C., Gaydos L.J., and Demers L.M. Dependence and reversal of nitric oxide production on NF-κB in silica and lipopolysaccharide-induced macrophages. Biochem. Biophys. Res. Commun. 214 (1995) 839-846
11. Cho C.H. Current roles of nitric oxide in gastrointestinal disorders. J. Physiol. Paris 95 (2001) 253-256
12. Cuzzocrea S., Chatterjee P.K., Mazzon E., McDonald M.C., Dugo L., Di Paola R., Serraino I., Britti D., Capiti A.P., and Thiemermann C. Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis. Eur. J. Pharmacol. 453 (2002) 119-129
13. D'Acquisto F., Iuvone T., Rombola L., Sautebin L., Di Rosa M., and Carnuccio R. Involvement of NF-κB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett. 418 (1997) 175-178
14. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J.R., and Knowles R.G. 1400W is a slow, tight binding and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo. J. Biol. Chem. 272 (1997) 4959-4963
15. Goodwin D.C., Landino L.M., and Marnett L.J. Reactions of prostaglandin endoperoxide synthase with nitric oxide and peroxynitrite. Drug Metab. Rev. 31 1 (1999) 273-294
16. Guo J.S., Cho C.H., Liu E.S.L., Choy H.T., Wang J.Y., and Koo M.W.L. Antiangiogenic effect of a highly selective COX-2 inhibitor on gastric ulcer healing in rats. Toxicol. Appl. Pharmacol. 183 (2002) 41-45
17. Guo J.S., Cho C.H., Wang W.P., Shen X.Z., Chen C.L., and Koo M.W.L. Expression and activities of three inducible enzymes in the healing of gastric ulcers in rats. World J. Gastroenterol. 9 (2003) 1767-1771
18. Guo J.S., Chen C.L., and Koo M.W.L. Inhibitory effects of centella aisatica water extract and asiaticoside on inducible nitric oxide synthase during gastric ulcer healing in rats. Planta Med. 70 (2004) 1150-1154
19. Jaiswal M., Larusso N.F., and Gores G.J. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am. J. Physiol. 281 (2001) G626-G634
20. Koarai A., Ichinose M., Sugiura H., Yamagata S., Hattori T., and Shirato K. Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice. Pulm. Pharmacol. Ther. 13 (2000) 267-275
21. Kojima M., Morisaki T., Izuhara K., Uchiyama A., Matsunari Y., Katano M., and Tanaka M. Lipopolysaccharide increases cyclooxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation. Oncogene 19 (2000) 1225-1231
22. Kolb H., and Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator?. Immunol. Today 19 (1998) 556-561
23. Lee P.C., Salyapongse A.N., Bragdon G.A., Shears II L.L., Watkins S.C., Edington H.D.J., and Billiar T.R. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am. J. Physiol. 46 (1999) H1600-H1608
24. Ma L., and Wallace J.L. Endothelial nitric oxide synthase modulates gastric ulcer healing in rats. Am. J. Physiol. 279 (2000) G341-G346
25. Menchén L.A., Colón A.L., Moro M.A., Leza J.C., Lizasoain I., Menchén P., Alevarez E., and Lorenzo P. N-(3-(Aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Life Sci. 69 (2001) 479-491
26. 2 production in experimental chronic gastric ulcer healing. Eur. J. Pharmacol. 519 (2005) 277-284
27. Radi R., Beckman J.S., Bush K.M., and Freeman R.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266 (1991) 4244-4250
28. Sanchez-Fidalgo S., Martin-Lacave I., Illanes M., Bruseghini L., Esteras A., and Motilva V. Administration of l-arginine reduces the delay of the healing process caused by ibuprofen. Implication of COX and growth factors expression. Histol. Histopathol. 20 (2005) 437-447
29. Schmedtje Jr. J.F., Ji Y.S., Liu W.L., DuBois R.N., and Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272 (1997) 601-608
30. Shigeta J., Takahashi S., and Okabe S. Role of cyclooxygenase-2 in the healing of gastric ulcers in rats. J. Pharmacol. Exp. Ther. 286 (1998) 1383-1390
31. Shin T., Tanuma N., Kim S., Jin J., Moon C., Kim K., Kohyama K., Matsumoto Y., and Hyun B. An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats. J. Neuroimmunol. 92 (1998) 133-138
32. Shinmura K., Xuan Y.T., Tang X.L., Kodani E., Han H., Zhu Y.Q., and Bolli R. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ. Res. 90 (2002) 602-608
33. Spiecker M., Peng H.B., and Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of iκBα. J. Biol. Chem. 272 (1997) 30969-30974
34. Takahashi S., Shigeta J., Inoue H., Tanabe T., and Okabe S. Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats. Am. J. Physiol. 275 (1998) G1137-G1145
35. Takahashi S., Fujita T., and Yamamoto A. Role of nuclear factor-κB in gastric ulcer healing in rats. Am. J. Physiol. 280 (2001) G1296-G1304
36. Tetsuka T., Daphna-Iken D., Miller B.W., Guan Z., Baier L.D., and Morrison A.R. Nitric oxide amplifies interleukin-1 induced cyclooxygenase-2 expression in rat mesangial cells. J. Clin. Invest. 97 (1996) 2051-2056
37. Tu K.F., Chan F.K.L., Cheng A.S.L., Lee T.L., Ng Y.P., and Sung J.J.Y. Up-regulation of cyclooxygenase-1 and -2 in human gastric ulcer. Aliment. Pharmacol. Ther. 15 (2001) 25-34
38. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., and Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U. S. A 91 (1994) 2046-2050
39. Wallace J.L. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112 (1997) 1000-1016
40. Warner T.D., Giuliano F., Vojnovic I., Bukasa A., Mitchell J.A., and Vane J.R. Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vivo analysis. Proc. Natl. Acad. Sci. U. S. A 96 (1999) 7563-7568
41. Whittle B.J.R. X-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors. Gut 47 (2000) 320-325